ZBIOZenas BioPharma, Inc.
$26.87+11% 1Y
$26.87
$15.2052 weeks$43.17
Is the price fair?
What ZBIO's price assumes
Zenas BioPharma, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1751× revenue.
1751
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 7.09
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 1331
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 7.09
- EV / EBIToperating margin −47557%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1331
- Market capitalisation65.2 million shares, counted Jul 31, 2026
- $1.75B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry